Protagonist Therapeutics (PTGX) PT Raised to $104 at Clear Street

March 18, 2026 3:39 PM

Clear Street analyst Kaveri Pohlman raised the price target on Protagonist Therapeutics (NASDAQ: PTGX) to $104.00 (from $91.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found